ADAPTIN BIO, INC.
APTN · OTCMCIK 1938571fmd_03XW5NM2NHG3BJ6H88RPED1FBHManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Jun 30, 2026, 16 periods
Latest annual · FY2025
Millions- Operating income
- (5)
- Net income
- (5)
Latest quarter · Q2 FY2026
Millions- Operating income
- (1)
- Net income
- (1)
ADAPTIN BIO, INC. (APTN) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$5.4 million | -$2.6 million | 10-K 2026-04-01 · proof | |
| Net income | -$5.2 million | -$3.1 million | 10-K 2026-04-01 · proof | |
| Cash from operating activities | -$4.8 million | -$649,283 | 10-K 2026-04-01 · proof | |
| Total assets | $619,159 | $239,415 | +158.6% | 10-K 2026-04-01 · proof |
| Total liabilities | $2.1 million | $4.3 million | -51.4% | 10-K 2026-04-01 · proof |
| Cash and cash equivalents | $459,174 | $34,085 | +1,247.1% | 10-K 2026-04-01 · proof |
- What was ADAPTIN BIO, INC. (APTN)'s operating income in fiscal 2025?
- ADAPTIN BIO, INC. (APTN) reported operating income of -$5.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was ADAPTIN BIO, INC. (APTN)'s net income in fiscal 2025?
- ADAPTIN BIO, INC. (APTN) reported net income of -$5.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What was ADAPTIN BIO, INC. (APTN)'s cash from operating activities in fiscal 2025?
- ADAPTIN BIO, INC. (APTN) reported cash from operating activities of -$4.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$649,283 the year before. Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are ADAPTIN BIO, INC. (APTN)'s total assets?
- As of Dec 31, 2025, ADAPTIN BIO, INC. (APTN) reported total assets of $619,159, against $239,415 a year earlier (+158.6%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are ADAPTIN BIO, INC. (APTN)'s total liabilities?
- As of Dec 31, 2025, ADAPTIN BIO, INC. (APTN) reported total liabilities of $2.1 million, against $4.3 million a year earlier (-51.4%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
- What are ADAPTIN BIO, INC. (APTN)'s cash and cash equivalents?
- As of Dec 31, 2025, ADAPTIN BIO, INC. (APTN) reported cash and cash equivalents of $459,174, against $34,085 a year earlier (+1,247.1%). Source: the 10-K filed with the SEC on Apr 1, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:APTN&period_type=annual&limit=5"Information only, not investment advice.